Average Co-Inventor Count = 11.24
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ligand Pharmaceuticals, Inc. (12 from 134 patents)
2. Chembridge Corporation (3 from 8 patents)
15 patents:
1. 11773110 - Heterocycle amines and uses thereof
2. 11413274 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
3. 11186593 - Heterocycle amines and uses thereof
4. 10736875 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
5. 10604533 - Heterocycle amines and uses thereof
6. 10111859 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
7. 10030034 - Heterocycle amines and uses thereof
8. 9622991 - Hematopoietic growth factor mimetic small molecule compounds and their uses
9. 9492430 - Methods and compositions associated with the granulocyte colony-stimulating factor receptor
10. 9266874 - Heterocycle amines and uses thereof
11. 9144557 - Hematopoietic growth factor mimetic small molecule compounds and their uses
12. 8815906 - Tyrosine kinase inhibitors
13. 8680150 - Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
14. 8629147 - Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
15. 8063225 - Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders